PubMed · 2001 · 125 citations · 73 references
Veterinary MedicineImmunologyPathologyImmunopathologyInflammationSepsisCytokine BiologyCytokine RegulationInflammatory Cell ResponsesInflammatory Response RegulationInflammatory SignalingSepsis PathophysiologyImmunosuppression After SepsisNuclear Factor Kappa B ActivationNuclear Factor Kappa B SignalingResponsivenessSepsis PathologySepsis-associated Cytokine DysregulationSepsis-associated Cytokine ResponseSepsis-associated Inflammation
Sepsis and non-infectious systemic inflammatory response syndrome (SIRS) are paradoxically associated with an exacerbated production of cytokines, as assessed by their presence in biological fluids, and a diminished ability of circulating leukocytes to produce cytokine upon in vitro activation. In this review, we depict that the observed cellular hyporeactivity is not a global phenomenon and that some signalling pathways are unaltered and allow the cells to respond normally to certain stimuli. Furthermore, we illustrate that during sepsis and SIRS, cells derived from tissues are either fully responsive to ex vivo stimuli or even primed, in contrast to cells derived from hematopoietic compartments (blood, spleen, etc.) which are hyporeactive. In addition to cytokine production, nuclear factor-kappa B (NF-kappa B) status within leukocytes can be used as a useful marker of hypo- or hyper-reactivity. We illustrate that the immune-depression reported in sepsis and SIRS patients, often revealed by a diminished capacity of leukocytes to respond to lipopolysaccharide, is not a generalized phenomenon and that SIRS is associated with a compartmentalized responsiveness which involves either anergic or primed cells.
73
S.T. O’Sullivan, James A. Lederer, Alan Horgan et al. · Annals of Surgery · 1995 · 501 citations · Full text
Life Sciences, Immunology, Pathology +17
Role of NFkappaB in the mortality of sepsis.
H. Böhrer, Fu Qiu, Thomas Zimmermann et al. · Journal of Clinical Investigation · 1997 · 463 citations · Full text